Skip to main content

Navigation group

Type at least 3 characters
1,248 articles

Articles

Original Research

Published on 29 Jul 2022

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

in General Cardiovascular Medicine

  • Lukas J. Motloch
  • Peter Jirak
  • Moritz Mirna
  • Lukas Fiedler
  • Paruir A. Davtyan
  • Irina A. Lakman
  • Diana F. Gareeva
  • Anton V. Tyurin
  • Ruslan M. Gumerov
  • Simon T. Matskeplishvili
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.916156
  • 3,909 views
  • 12 citations